Magnesium citrate

Phase 3Small molecule

MMethodist Health System

Magnesium citrate is one of 3 small molecule programs targeting Constipation. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CalciphylaxisRecruiting

CalciphylaxisPhase 3

Recruiting

Competition

Competitive Landscape

2 competitors in Calciphylaxis

#DrugCompanyPhaseTrials

Sodium Thiosulfate

HHope Pharmaceuticals

Phase 3

1 2

Magnesium citrate

MMethodist Health System

Phase 3

1 3

Actemra

CCelltrion

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Post-ApprovalRecruiting

Magnesium Deficiency

NCT03088852

Q4 2029

Phase 3Recruiting

Calciphylaxis

NCT05018221

Clinical

Trials by Indication[1]

Magnesium Deficiency1 trial

Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards

Recruiting·FFrieda Wolf·Phase 4·NCT03088852·330 enrolled

Calciphylaxis1 trial

Better Evidence and Translation for Calciphylaxis

Recruiting·UUniversity of Sydney·Phase 3·NCT05018221·350 enrolled

Pregnancy1 trial

A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy

Completed·PProfessor Fernando Figueira Integral Medicine Institute·Phase 3·NCT02032186·3,000 enrolled

Constipation1 trial

RELISTOR's Effects on Opioid-Induced Constipation

Withdrawn·MMethodist Health System··NCT04930237

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Magnesium citrate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Magnesium citrate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Magnesium citrate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Methodist Health System company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: MMethodist Health System

Magnesium citrate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q4 2029

Trials by Indication[1]

Magnesium Deficiency1 trial

Calciphylaxis1 trial

Pregnancy1 trial

Constipation1 trial

References

Drug Info

Quick Facts

Related News